Consensus Shanghai Junshi Biosciences Co., Ltd. Deutsche Boerse AG

Equities

8SJ

CNE100003FF7

Delayed Deutsche Boerse AG Other stock markets 08:59:01 04/06/2024 BST			5-day change	1st Jan Change
1.41 ^EUR	+6.82%		+10.16%	-45.77%

04-29	Shanghai Junshi Biosciences Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-25	Shanghai Junshi Biosciences Receives Hong Kong Approval for Cancer Drug Toripalimab	MT

Evolution of the average Target Price on Shanghai Junshi Biosciences Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

cc092d3334a9d3c26afc.MyujfSxNywND9YvnEaVx5aFslZ731lyfG-1GmyheIB4.aWqVOG85_mgowO6uXeAIspJdwtSQoQTJSok18xsxE0trH-0tFSmUSDGQ_A~6d0c298caa94ef27f0ddb2c2e02005c0

Analyst Recommendations on Shanghai Junshi Biosciences Co., Ltd.

Shanghai Junshi Biosciences' 2022 Loss Widens, Misses Analysts' Expectations	28/02/23	MT
UBS Adjusts Shanghai Junshi Biosciences' Price Target to HK$65.40 From HK$70.90, Keeps at Buy	05/09/22	MT
UBS Adjusts Shanghai Junshi Biosciences’ Price Target to HK$70.90 From HK$77.70, Keeps at Buy	26/05/22	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

10.82 CNY

Average target price

22.86 CNY

Spread / Average Target

+111.32%

High Price Target

42.1 CNY

Spread / Highest target

+289.17%

Low Price Target

11.12 CNY

Spread / Lowest Target

+2.78%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Shanghai Junshi Biosciences Co., Ltd.

UBS

Ratings for Shanghai Junshi Biosciences Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar